C. Evan Ballantyne
2015 - Synthetic Biologics
In 2015, C. Evan Ballantyne earned a total compensation of $716.2K as Former Chief Financial Officer at Synthetic Biologics, a 16% decrease compared to previous year.
Compensation breakdown
| Option Awards | $297,167 |
|---|---|
| Salary | $124,356 |
| Other | $294,711 |
| Total | $716,234 |
Ballantyne received $297.2K in option awards, accounting for 41% of the total pay in 2015.
Ballantyne also received $124.4K in salary and $294.7K in other compensation.
Rankings
In 2015, C. Evan Ballantyne's compensation ranked 9,440th out of 13,638 executives tracked by ExecPay. In other words, Ballantyne earned more than 30.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,440 out of 13,638 | 31st |
Division Manufacturing | 3,594 out of 5,187 | 31st |
Major group Chemicals And Allied Products | 1,314 out of 1,857 | 29th |
Industry group Drugs | 1,072 out of 1,531 | 30th |
Industry Pharmaceutical Preparations | 833 out of 1,179 | 29th |
Source: SEC filing on July 6, 2016.
Ballantyne's colleagues
We found two more compensation records of executives who worked with C. Evan Ballantyne at Synthetic Biologics in 2015.